Amicus Therapeutics, Inc. (FOLD)

Amicus Therapeutics Revenue

In the year 2025, Amicus Therapeutics had annual revenue of $634.21M with 20.05% growth. Amicus Therapeutics had revenue of $185.21M in the quarter ending December 31, 2025, with 23.72% growth.

• Revenue (ttm): $634.21M
• Revenue Growth: +20.05%
• P/S Ratio: 7.17
• Revenue / Employee: $1,241,115
• Employees: 511
• Market Cap: 4.55B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	634.21M	105.92M	20.05%
Dec 31, 2024	528.30M	128.94M	32.29%
Dec 31, 2023	399.36M	70.12M	21.30%
Dec 31, 2022	329.23M	23.72M	7.76%
Dec 31, 2021	305.51M	44.63M	17.11%
Dec 31, 2020	260.89M	78.65M	43.16%
Dec 31, 2019	182.24M	90.99M	99.72%
Dec 31, 2018	91.25M	54.32M	147.08%
Dec 31, 2017	36.93M	31.97M	644.86%
Dec 31, 2016	4.96M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	1.22M	861.00K	237.19%
Dec 31, 2013	363.00K	-18.05M	-98.03%
Dec 31, 2012	18.41M	-3.02M	-14.10%
Dec 31, 2011	21.43M	20.51M	2,224.73%
Dec 31, 2010	922.00K	-63.44M	-98.57%
Dec 31, 2009	64.36M	49.39M	330.00%
Dec 31, 2008	14.97M	13.18M	738.96%
Dec 31, 2007	1.78M	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jan 1, 2000

Data Sources Report a data error